Enjoyed speaking about immunology with Jatin and Eugenio of Antibuddies Podcast this week - check out their other episodes immunology and human disease, too! x.com/AntibuddiesP/s…

melissalechner.wixsite.com/melissalechner…

melissalechner.wixsite.com/melissalechner…

Great to see my dear medical school friend Alexis E. Dixon, MD being awesome! Wouldn’t trust anyone else with my precious runner feet. laweekly.com/the-heal-insti…

Check it out from Dr. Willy Hugo UCLA New insights into anti-PD1 response in melanoma: Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors biorxiv.org/content/10.110…

Tackling checkpoint inhibitor endocrine autoimmune toxicities with great colleagues at the Fred Hutch Cancer Center - youtube.com/watch?v=8U3eBl…

1/25. Our work out in Journal of Clinical Oncology! Real-world report from the CATCH-IT consortium. Fortunate to share this journey w/ co-authors, co-first authors @adib_Elio, Talal El Zarif, MD and under the mentorship of #naqashlab Guru P. Sonpavde, MD! Yale Cancer Center, @DanaFarberNews@YaleIMed. Tweetorial below:

Shedding new light on the dark side of cancer immunotherapy - mechanisms of IRAEs. Just out in Science Translational Medicine, grateful for support from UCLA Health and American Thyroid Association and my collaborators Trevor E Angell MD Maureen Su Lab wix.to/yPSqMbG

Can't wait to read this - always insightful work from the Landa Lab

Su-Lechner labs happy to be on winter break! wix.to/ykyAwCq

Congratulations to Sarah and Nicole - Uncovering the pathogenesis and potential therapy for ICI-Diabetes at Endo Society this week.#Endo2024 wix.to/8rciuVB

Increased IRAEs in Breast Cancer Patients Treated with RANKL inhibitor Denosumab + Checkpoint Inhibitor - Podium talk at San Antonio Breast Cancer Symposium by Dr. LeVee UCLA Alexis LeVee, MD @ Cityofhope SABCS wix.to/e7qmcW5

Jarod, Kyleigh, and Jaden excel at ATA Chicago 2024 aime franco American Thyroid Association UCLA Health wix.to/4F8dAvv

New research on IrAE mechanisms and risk factors at the 2024 SITC meeting, wix.to/MRpJGem

We are shutting down the labs and many are displaced. Grateful for our colleagues and friends during this challenging time at UCLA. 💙 wix.to/4Au3fAB

UCLA is now an NIH Autoimmune Center of Excellence. This represents a significant milestone in our dedication to innovative research in autoimmunity and excited to be a part of this group. wix.to/UaWTWMh #UCLA #Autoimmunity

Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring | Science | AAAS science.org/content/articl…

New research alert! We explore strategies to reverse checkpoint inhibitor diabetes in our latest publication. Insights on autoimmune side effects from cancer treatments await you! Check it out: wix.to/AEKj4c4 #uclaitox #CancerResearch #Diabetes

ENDO 2025 - Excited to collaborate with UCSF, USC, U Colorado, and UNC Chapel Hill on our multi-center trial aiming to tackle ICI-Diabetes. Innovation in cancer treatment is our goal! Read more: wix.to/M8Grg8F #CancerResearch #ICI

Congratulations to Kyleigh Kimbrell for her recognition at the 2025 ATA meeting for research excellence in thyroid autoimmunity and sex differences! This is a crucial area of study that needs more attention. wix.to/CRrSXo0 #WomenInSTEM American Thyroid Association UCLA Health